-
Study Shows That Therapeutic Drug Monitoring Can Reduce Chemotherapy Side Effects
Saladax Biomedical, Inc., an anchor tenant at Ben Franklin TechVentures®, announced the publication of a practice-changing study that shows the benefits of measuring and adjusting the amount of chemotherapy in a patient’s blood to minimize debilitating toxicity. Saladax has developed tests for Therapeutic Drug Monitoring (TDM), measuring and adjusting drug doses to reach a target. Chemotherapy-induced Continue Reading…